Evidence map›Paper›PMID 35058982›Full record

ArticleJournal of oncology2022

Application of Circulating Tumor Cells and Circulating Free DNA from Peripheral Blood in the Prognosis of Advanced Gastric Cancer.

Pengjie Yu, Shengmao Zhu, Yushuang Luo, Ganggang Li, Yongqiang Pu, Baojia Cai, Chengwu Zhang

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Novel Liquid Biopsy in Gastrointestinal Cancers.Journal of gastroenterology and hepatology · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Pengjie YuDepartment of Gastrointestinal Oncology, Affiliated Cancer Hospital of Qinghai University, Affiliated Hospital of Qinghai University, Xining, China.
Shengmao ZhuDepartment of Gastrointestinal Oncology, Affiliated Cancer Hospital of Qinghai University, Affiliated Hospital of Qinghai University, Xining, China.
Yushuang LuoInternal Medicine-Oncology, Affiliated Cancer Hospital of Qinghai University, Affiliated Hospital of Qinghai University, Xining, China.
Ganggang LiThe Fifth People's Hospital of Qinghai Province, Xining, China.
Yongqiang PuDepartment of Gastrointestinal Oncology, Affiliated Cancer Hospital of Qinghai University, Affiliated Hospital of Qinghai University, Xining, China.
Baojia CaiDepartment of Gastrointestinal Oncology, Affiliated Cancer Hospital of Qinghai University, Affiliated Hospital of Qinghai University, Xining, China.
Chengwu ZhangDepartment of Gastrointestinal Oncology, Affiliated Cancer Hospital of Qinghai University, Affiliated Hospital of Qinghai University, Xining, China.ORCID https://orcid.org/0000-0003-2720-1227
Qinghai University Affiliated Hospital · CNQinghai No.3 People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo explore the application value of circulating tumor cells (CTCs) and circulating free DNA (cfDNA) from peripheral blood in the prognosis of advanced gastric cancer (AGC). Here, we measured CTCs and cfDNA quantity for predicting the outcome of patients.

resultsAmong 45 patients, 43 (95.6%) were positive, and the positive rate of mesenchymal CTC was increased with the increase in the T stage. The proportion of mesenchymal CTC was positively correlated with the N stage (

conclusionsPeripheral blood CTC, especially interstitial CTC and cfDNA, has a certain value in predicting the efficacy and prognosis of neoadjuvant chemotherapy in advanced gastric cancer.

Identifiers

PMID35058982
PMCPMC8766178
OpenAlexW4206726660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.